慢性淋巴细胞白血病的预后因素 - 旧的,新的和未来的
Sean McKeague1, Constantine Tam2,3
1Department of Haematology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
Leukemia & lymphoma
|January 8, 2025
概括
慢性淋巴细胞白血病 (CLL) 的预后因素随着新疗法的发展而演变. 虽然化疗免疫疗法依赖于IGHV,TP53和型,但针对性疗法,如BCL2抑制剂和BTK抑制剂,对这些标记物有不同的依赖性.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 预后评估对于个性化慢性淋巴细胞白血病 (CLL) 治疗至关重要.
- 传统的预后标记包括TP53状态,型和IGHV突变状态.
研究的目的:
- 通过不同治疗时期审查预后因素在CLL中的演变作用.
- 评估新型向治疗对预后标志物相关性的影响.
主要方法:
- 对CLL的预后标志物进行文献综述.
- 在化疗免疫疗法 (CIT),BCL2抑制剂 (BCL2i) 和BTK抑制剂 (BTKi) 治疗环境中预后因素影响的分析.
主要成果:
- 对于BCL2i来说,IGHV状态,TP53状态,型和MRD仍然很重要.
- BTKi疗效不太依赖于IGHV和TP53状态.
- 卡特-T疗法反应似乎独立于TP53状态,但依赖于T细胞适应性.
结论:
- 随着新的CLL疗法,预后标记的相关性发生了变化.
- 了解这些不断变化的因素是优化治疗策略的关键.
相关概念视频
01:27Disorders of Leukocytes
846
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
846
02:07Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K